[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359881-105":59,"doc-detail-359881-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","anticancer-activity-of-an-apigenin-functionalized-silica-coated-silver-oxide-nanocomposite-against-human-gastric-adenocarcinoma-cells-ags-in-vitro-and-insilico-analysis","Anticancer activity of an apigenin-functionalized silica-coated silver oxide nanocomposite against human gastric adenocarcinoma cells (AGS) - in vitro and insilico analysis","","Silver nanoparticles show promise anticancer agents, yet clinical translation is limited by poor bioavailability and nonspecific toxicity. This study developed an apigenin-functionalized silica-coated silver oxide nanocomposite (Ag2O@SP@Apigenin) and evaluated anticancer activity against AGS human gastric adenocarcinoma cells. The composite was synthesized and characterized using FTIR, FE-SEM, TEM, and thermal and other analyses, showing ~99.45 nm spherical morphology and high thermal stability. MTT assays and wound-healing tests demonstrated dose-dependent cytotoxicity and reduced migration, while gene expression analyses indicated miR-181a downregulation with pro-apoptotic and apoptotic target upregulation; in silico docking supported multitarget interactions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/anticancer-activity-of-an-apigenin-functionalized-silica-coated-silver-oxide-nanocomposite-against-human-gastric-adenocarcinoma-cells-ags-in-vitro-and-insilico-analysis/359881/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/anticancer-activity-of-an-apigenin-functionalized-silica-coated-silver-oxide-nanocomposite-against-human-gastric-adenocarcinoma-cells-ags-in-vitro-and-insilico-analysis/359881.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What nanocomposite was developed and why?","Question",{"text":112,"@type":113},"The study developed an apigenin-functionalized silica-coated silver oxide nanocomposite (Ag2O@SP@Apigenin) to improve anticancer performance while addressing limitations like poor bioavailability and nonspecific toxicity associated with silver nanoparticles.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the nanocomposite synthesized and verified experimentally?",{"text":117,"@type":113},"Ag2O@SP@Apigenin was synthesized via chemical reduction, followed by silica coating using 3-chloropropyltrimethoxysilane, and apigenin functionalization under alkaline conditions. Characterization used FTIR, FE-SEM, TEM, TGA, and complementary analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What results were observed for cancer cell viability and migration?",{"text":121,"@type":113},"MTT assays showed dose-dependent cytotoxicity against AGS gastric adenocarcinoma cells with reported IC50 values at 24 and 48 hours. Wound-healing assays indicated inhibition of AGS cell migration, and gene expression data supported apoptosis-related pathway modulation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359881,1790181939,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Mousavi Eshkelani etal. BMC Biotechnology (2026) 26:58  \n[https://doi.org/10.1186/s12896-026-01118-0](https://doi.org/10.1186/s12896-026-01118-0)  \nBMC Biotechnology  \nRESEARCH Open Access  \nAnticancer activity of an apigeninfunctionalized silica-coated silver oxide nanocomposite against human gastric adenocarcinoma cells (AGS): in vitro and insilico analysis  \nSeyed Milad Mousavi Eshkelani 1, Reyhaneh Kouchakinejad2, Sara Dabirian3, Parastoo Vakilinezami1, Kamyab Shokrani1, Hamed Tajmehri1, Hossein Zahmatkesh4, Mahdi Shahriarinour1, Behnam Rasti5, Mohammad Nikpassand2* and Najmeh Ranji 1*  \nAbstract  \nSilver nanoparticles show promise anticancer agents, yet their clinical translation is hindered by poor bioavailability and nonspecific toxicity. In this study, we developed an apigenin-functionalized silica-coated silver oxide nanocomposite (Ag2O@SP@Apigenin) and evaluated its anticancer activity against AGS human gastric adenocarcinoma cells. Silver nanoparticles were synthesized via chemical reduction, followed by silica-coated using 3-chloropropyltrimethoxysilane, and functionalization with apigenin under alkaline conditions. Successful synthesis and surface modification were confirmed by FTIR, FE-SEM, TEM, TGA, and complementary analyses. The nanocomposite exhibited a spherical morphology with an average size of 99.45 nm. Thermal analysis revealed high stability, with only 2. 572% weight loss and structural integrity maintained up to 303 °C. MTT assays demonstrated dose-dependent cytotoxicity of Ag2O@SP@Apigenin against AGS gastric cancer cells, with IC50 values of 41.45 µg/ mL and 34.41 µg/mL after 24 and 48 h, respectively. In addition, Ag2O@SP@Apigenin exhibited IC50 values of  \n51.73 µg/mL and 35.29 µg/mL on HT-20 colorectal cancer cells after 24 and 48 h, respectively. Similarly, the IC50 values were 38.84 µg/mL and 16.733 µg/mL against U87 glioblastoma cancer cell after 24 and 48 h, respectively. In contrast, both apigenin powder and Ag2O@SP nanocomposites reduced cancer cell viability to a significantly greater extent than did the Ag2O@SP@Apigenin composite. Wound-healing assays indicated that Ag2O@SP@ Apigenin inhibited AGS cell migration by 42. 99%±17 . 38% after 24 h. Q-RT-PCR analysis revealed downregulation of miR-181a (0 . 36 ± 0.03 fold), along with upregulation of its potential targets, including the apoptotic genes APAF1 (2 . 15 ± 0.09 fold), P53 (1 .71 ± 0.04 fold), and CASP9 (1 . 55 ± 0.23 fold), in treated AGS cells. Additionally,  \n*Correspondence:  \nMohammad Nikpassand [Mohammad.nikpassand@iau.ac.ir](Mohammad.nikpassand@iau.ac.ir)[ ](Mohammad.nikpassand@iau.ac.ir)Najmeh Ranji  \n[na.ranji@iau.ac.ir](na.ranji@iau.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nMousavi Eshkelani et al. BMC Biotechnology (2026) 26:58 Page 2 of 22  \ndownregulation of ","cbCaivmWplr74oq2","https://ap.wps.com/l/cbCaivmWplr74oq2","pdf",5732209,22,"English","# Abstract\n## Methods and characterization\n## Anticancer evaluation (MTT, wound healing)\n## Molecular analyses (q-RT-PCR, miR-181a/miR-34a)\n## In silico docking and conclusions\n# Introduction\n## Background on silver nanoparticles\n## Role of apigenin and nanoparticle synthesis","[{\"question\":\"What nanocomposite was developed and why?\",\"answer\":\"The study developed an apigenin-functionalized silica-coated silver oxide nanocomposite (Ag2O@SP@Apigenin) to improve anticancer performance while addressing limitations like poor bioavailability and nonspecific toxicity associated with silver nanoparticles.\"},{\"question\":\"How was the nanocomposite synthesized and verified experimentally?\",\"answer\":\"Ag2O@SP@Apigenin was synthesized via chemical reduction, followed by silica coating using 3-chloropropyltrimethoxysilane, and apigenin functionalization under alkaline conditions. Characterization used FTIR, FE-SEM, TEM, TGA, and complementary analyses.\"},{\"question\":\"What results were observed for cancer cell viability and migration?\",\"answer\":\"MTT assays showed dose-dependent cytotoxicity against AGS gastric adenocarcinoma cells with reported IC50 values at 24 and 48 hours. Wound-healing assays indicated inhibition of AGS cell migration, and gene expression data supported apoptosis-related pathway modulation.\"}]","Anticancer activity of an apigenin-functionalized silica-coated silver oxide nanocomposite against human gastric adenocarcinoma cells (AGS) - in vitro and insilico analysis | PDF",1790138088,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be8332334ec5bc185cfb527a30997cfc.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/807d9620566220419df2e6bce06f4028.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f6bfeb6355c8e9967db5093f835c471.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d56691267ef2fc36ee70c8701e6160c7.webp",980,1306]